Preclinical pharmacologic studies on 1-nitro-9-(dimethylamino)-acridine and 1-nitro-10-(dimethylaminoethyl)-9-acridone. II. Chronic action.
D000166:Acridines / Q000494:pharmacology / Q000633:toxicity*; D000818:Animals; D001853:Bone Marrow / Q000187:drug effects; D004123:Dimethylamines / Q000494:pharmacology / Q000633:toxicity; D004353:Drug Evaluation, Preclinical; D005021:Ethylamines / Q000494:pharmacology / Q000633:toxicity; D005260:Female; D006066:Gonads / Q000187:drug effects; D006321:Heart / Q000187:drug effects; D007267:Injections / Q000379:methods; D007275:Injections, Intravenous; D007422:Intestines / Q000187:drug effects; D007668:Kidney / Q000187:drug effects; D007928:Lethal Dose 50; D008099:Liver / Q000187:drug effects; D008198:Lymph Nodes / Q000187:drug effects; D008297:Male; D008643:Mesentery; D009574:Nitro Compounds / Q000494:pharmacology / Q000633:toxicity; D011817:Rabbits; D051381:Rats; D013950:Thymus Gland / Q000187:drug effects; D013997:Time Factors
D000166:Acridines; D004123:Dimethylamines; D005021:Ethylamines; D009574:Nitro Compounds